KELLY MCAULIFFE: Open Payments
NPI 1629168745 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 98 payments from 24 companies in 2025. Trend: 2023 $2,003 · 2024 $1,861 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $350 |
| Novo Nordisk Inc | 14 | $204 |
| PFIZER INC. | 12 | $183 |
| Lilly USA, LLC | 8 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
Products named: UBRELVY, Ozempic, QULIPTA, NURTEC ODT, MOUNJARO, XIFAXAN, JARDIANCE, CAPLYTA.
Industry payments across VA — which companies pay providers there.
